Brief: VBL Therapeutics Reports Q1 Revenue Of $185,000
11/05/2021 13:55
May 11 (Reuters) - VBL Therapeutics VBLT.O :
* VBL THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* Q1 REVENUE $185,000 VERSUS REFINITIV IBES ESTIMATE OF
$200,000
* CASH POSITION EXPECTED TO FUND OPERATIONS UNTIL YEAR-END
2023
Source text for Eikon: ID:nGNX7xvpYL
Further company coverage: VBLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives